| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/08/2002 | WO2002060374A2 Benz-1,3-azole derivatives and their uses as heparanase inhibitors |
| 08/08/2002 | WO2002060373A2 Indole derivatives and their uses as heparanase inhibitors |
| 08/08/2002 | WO2002038541A9 Cyanopyrrolidine derivatives |
| 08/08/2002 | WO2002034903A3 Nucleic acid generating the abca7 gene, molecules modulating its activity and therapeutic applications |
| 08/08/2002 | WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2002022161A3 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 08/08/2002 | WO2002020762A3 Tnf receptor-like molecules and uses thereof |
| 08/08/2002 | WO2002011735A3 Association of a purine activity and a nonsteroidal anti-inflammatory anti-inflammatory drug for treating sexual dysfunction |
| 08/08/2002 | WO2002011665A3 Association of a purine and a nonsteroidal anti-inflammatory drug for treating sexual dysfunction |
| 08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
| 08/08/2002 | WO2002005801A3 Compositions containing diacyltartaric salts of (e)-metanicotine |
| 08/08/2002 | WO2002000840A3 Human lyases |
| 08/08/2002 | WO2002000631A3 Benzhydryl derivatives |
| 08/08/2002 | WO2001098268A3 Piperidine amides as modulators of chemokine receptor activity |
| 08/08/2002 | WO2001096546A3 Protein phosphatases |
| 08/08/2002 | WO2001095899A3 Pharmaceutical compositions comprising cannabidiol derivatives |
| 08/08/2002 | WO2001094312A3 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
| 08/08/2002 | WO2001090361A3 Modulation of inflammation by protease-treated mcp-3 chemokine |
| 08/08/2002 | WO2001090330A3 AMINOACYL tRNA SYNTHETASES |
| 08/08/2002 | WO2001085150A3 Opioid antagonist containing composition for enchaching the potency or reducing adverse side effects ofopioid agonists |
| 08/08/2002 | WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec) |
| 08/08/2002 | WO2001081312A3 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 08/08/2002 | WO2001077376A3 Diagnosis of diseases associated with metastasis |
| 08/08/2002 | WO2001076451A9 Diagnosis of diseases associated with metabolism |
| 08/08/2002 | WO2001064685A3 Thienopyridine derivatives and their use as anti-inflammatory agents |
| 08/08/2002 | WO2001051641A9 Irak-4: compositions and methods of use |
| 08/08/2002 | WO2001009328A9 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 08/08/2002 | WO2001009090A3 Hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines |
| 08/08/2002 | US20020107372 Nucleotide sequences coding membrane protein for use in the treatment of inflammation,lung defects and viral diseases |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107359 Protein model for use in drug design in human therapeutics |
| 08/08/2002 | US20020107289 Regulation of phospholipase D activity |
| 08/08/2002 | US20020107280 Selective COX II inhibitor |
| 08/08/2002 | US20020107276 Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107271 Heterocyclic aromatic oxazole compounds and use thereof |
| 08/08/2002 | US20020107270 Selective inhibitory action on cyclooxygenase- 2 and are expected to be useful as anti-inflammatory agents with less side-effects such as digestive tract disorders. |
| 08/08/2002 | US20020107263 Squaric acid derivatives |
| 08/08/2002 | US20020107259 Analgesic combination of oxycodone and SC-58215 |
| 08/08/2002 | US20020107255 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes). |
| 08/08/2002 | US20020107252 Novel Compounds |
| 08/08/2002 | US20020107251 4-(hetero)aryl-3-oxo-3,4-dihydropyrido(2,3-b)pyrazine derivatives; prophylactic or therapeutic treatment of phosphodiesterase IV and tumor necrosis factor mediated diseases |
| 08/08/2002 | US20020107235 Carbamate and hydroxy groups containing phenanthrene derivatives; useful to treat obesity, diabetes and inflammation |
| 08/08/2002 | US20020107210 Compositions and methods for the treatment of autoimmune diabetes |
| 08/08/2002 | US20020107178 Methods and preparations for curing clinically ill patients |
| 08/08/2002 | US20020106780 Extracellular matrix polynucleotides, polypeptides, and antibodies |
| 08/08/2002 | US20020106746 Nucleotide sequences coding preferential protein for use in the treatment of septic shock, liver and immunological, tumors and connective tissue defects |
| 08/08/2002 | US20020106732 Smad6 and uses thereof |
| 08/08/2002 | US20020106726 Peptide for use in the treatment of inflammation defects |
| 08/08/2002 | US20020106655 Nucleotide sequences coding preferential protein for use in the treatment, diagnosis and prevention of immunological, nervous system and tumor disorders |
| 08/08/2002 | US20020106371 For therapy of sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura |
| 08/08/2002 | US20020106338 Galenical formulation |
| 08/08/2002 | CA2438594A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | CA2436770A1 Methods of treating inflammatory and immune diseases using inhibitors of ikb kinase (ikk) |
| 08/08/2002 | CA2436748A1 Method of using a variant of vegf receptor to treat psoriasis and to enhance wound healing |
| 08/08/2002 | CA2436551A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436544A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436535A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | CA2436487A1 Methods of inhibiting kinases |
| 08/08/2002 | CA2436411A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | CA2436266A1 Pyk2 phosphorylation by her3 induces tumor invasion |
| 08/08/2002 | CA2436130A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | CA2434953A1 Protein modification and maintenance molecules |
| 08/08/2002 | CA2434491A1 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | CA2432997A1 Antagonists of mcp-1 function and methods of use thereof |
| 08/08/2002 | CA2432731A1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 08/08/2002 | CA2432642A1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | CA2432369A1 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | CA2431559A1 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/08/2002 | CA2427610A1 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/07/2002 | EP1229035A1 Imine intermediates for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties |
| 08/07/2002 | EP1229034A1 Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes |
| 08/07/2002 | EP1228766A1 PYK2 phosphorylation by HER3 induces tumor invasion |
| 08/07/2002 | EP1228760A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 08/07/2002 | EP1228222A2 Human transferase molecules |
| 08/07/2002 | EP1228221A2 Human sphingosine kinase gene |
| 08/07/2002 | EP1228203A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 08/07/2002 | EP1228201A1 High order nucleic acid based structures |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228088A2 Novel traf family proteins |
| 08/07/2002 | EP1228082A1 29 human secreted proteins |
| 08/07/2002 | EP1228076A1 A substantially cell membrane impermeable compound and use thereof |
| 08/07/2002 | EP1228073A2 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 08/07/2002 | EP1228072A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 08/07/2002 | EP1228071A1 Pharmaceutically active isoindoline derivatives |
| 08/07/2002 | EP1228070A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 08/07/2002 | EP1228068A1 Polymorphic form of a tachykinin receptor antagonist |
| 08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
| 08/07/2002 | EP1228063A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 08/07/2002 | EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228059A1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228054A1 Compounds and their use as cysteine protease inhibitors |
| 08/07/2002 | EP1228046A1 Phthalazinone derivatives as pde 4 inhibitors |
| 08/07/2002 | EP1228042A2 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 08/07/2002 | EP1228039A1 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 08/07/2002 | EP1228037A1 Compounds having mif antagonist activity |
| 08/07/2002 | EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |